HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12
HTG Molecular Diagnostics (Nasdaq: HTGM) will release its financial results for Q1 2022 on May 12, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (Nasdaq: HTGM) will release its financial results for Q1 2022 on May 12, 2022, after market close. A conference call is scheduled for 4:30 PM ET to discuss the results and provide a corporate update. HTG focuses on advancing precision medicine through transcriptome-wide profiling, aiding translational research, clinical diagnostics, and targeted therapeutics. Its proprietary RNA platform aims to revolutionize drug discovery and diagnostics across various disease areas.
Positive
- HTG is advancing precision medicine, which may lead to significant market opportunities.
- The company has established partnerships with biopharma leaders and academic institutions, enhancing its credibility.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was -8.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., May 05, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended March 31, 2022 after the market close on Thursday, May 12, 2022.
Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the conference call are as follows:
| Conference Call & Webcast Details | |
| Date: | Thursday, May 12 |
| Time: | 4:30pm ET |
| Toll Free: | 1-855-327-6837 |
| International: | 1-631-891-4304 |
| Conference ID: | 10019008 |
| Webcast: | https://services.choruscall.com/mediaframe/webcast.html?webcastid=zldEP8Ko |
About HTG:
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.
Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.
HTG Investor Contact:
Ashley Robinson
LifeSci Advisors
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.